To reduce the time dedicated to clone screening in the development of cell lines for stable virus production, a protocol merging the procedures of cell cloning and titer screening was implemented: the ...
Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback